Market Assessment Underway by PTSC to Complement Strong Product Review

CARLSBAD, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Patriot Scientific
Corporation (OTC Bulletin Board: PTSC) announced that Eclat Consulting, LLC,
("Eclat") will launch a market validation study of the Company's flagship
technology, the Crossflo DataExchange® platform ("CDX"). This follows on the
heels of a completed independent assessment conducted by a Fortune 1000
technology firm in which CDX scored very high marks in all significant
categories including product stability, code quality, and overall design
rigor.

The Eclat team, lead by CEO Greg Baroni, recently assisted the Company with an
assessment of key management, and has also been working with the Company to
identify strategic options for the Company's wholly owned subsidiary, Patriot
Data Solutions Group ("PDSG"). Patriot's Board engaged Eclat's team of
experienced business consultants to help assess the strategic direction of
PDSG and to assist in identifying the optimum operational structure and focus
of PDSG.

In addition, Eclat is assisting the Company in its search for a Chief
Executive Officer with targeted industry experience able to take the company
to the next level of growth and revenue. The market validation study will be
an essential tool in framing the competencies sought for the CEO candidate.

About Eclat Consulting, LLC ("Eclat")
Eclat - literally, "brilliance of success." And, put simply, our success is
defined by the brilliance of our clients' success. We are a different kind of
professional services company - problem solvers who deliver tangible
performance improvements. Eclat delivers a comprehensive range of services,
including strategic, operational support, healthcare, security, and
application services. Proven performance and forward thinking - it's Eclat's
foundation. For more information on how Eclat is different, visit:
www.eclatllc.com.

About Patriot Scientific

Headquartered in Carlsbad, California, Patriot Scientific Corporation provides
data sharing and secure data solutions for a connected world. Patriot
Scientific addresses the expanding market opportunities in the healthcare,
justice and public safety industries through its wholly owned subsidiary
Patriot Data Solutions Group, Inc. These growth activities are funded with
revenues generated, in a large part, from the continuing successful Moore
Microprocessor Patent(TM) Portfolio licensing partnership with The TPL Group.
Patriot Scientific's integrated core intelligence solution addresses the
critical data/information sharing needs of the healthcare industry, the
Department of Homeland Security, the Department of Justice, and federal,
state, and local public safety and law enforcement agencies. For more
information on Patriot Scientific Corporation, visit: www.ptsc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: Statements in this news release looking forward in time involve risks
and uncertainties, including the risks associated with the effect of changing
economic conditions, trends in the products markets, variations in the
company's cash flow, market acceptance risks, patent litigation, technical
development risks, seasonality and other risk factors detailed in the
company's Securities and Exchange Commission filings.

Contact:
Angela Hartley
Investor Relations
ir@ptsc.com
760-547-2700 ext. 102

SOURCE Patriot Scientific Corporation

Angela Hartley, Investor Relations of Patriot Scientific Corporation,
+1-760-547-2700, ext. 102, ir@ptsc.com